How Epigenetics Drives Salt-Sensitive Hypertension and What It Means for You

Salt-sensitive hypertension (SSH) is a clinically important but under-recognized phenotype in which blood pressure rises significantly with dietary salt intake. Unlike standard hypertension, SSH reflects a maladaptive interaction between genetic predisposition and environmental exposures—and new evidence places epigenetic regulation at the center of this dysregulation.

This review from researchers at IRCCS San Raffaele Scientific Institute in Milan synthesizes current evidence across three major epigenetic mechanisms. DNA methylation patterns at specific CpG sites have been linked directly to SSH-relevant genes: cg09680149 near SCNN1A (encoding the ENaC alpha subunit governing sodium transport), cg00805360 near ADAM8 (involved in endothelial-to-mesenchymal transition and cardiac fibrosis), and cg00574958 near CPT1A (fatty acid beta-oxidation), which correlates significantly with systolic blood pressure. In Dahl salt-sensitive rats, high-salt feeding produces distinct methylation profiles in the renal outer medulla, mirroring human hypertensive phenotypes.

Histone modifications add another regulatory layer. In spontaneously hypertensive rats, KDM5A demethylase binding to the ACE1 promoter enriches activating H3K4me3 marks while depleting repressive H3K9me2, upregulating ACE1 and amplifying angiotensin II production. Aldosterone-activated SGK1 disrupts the Af9-Dot1a repressor complex at the ENaC promoter, reducing H3K79me3 and increasing sodium reabsorption. HDAC inhibition, meanwhile, boosts nitric oxide synthase expression and vasodilation in salt-sensitive animal models. A dietary intervention study in 339 Chinese subjects found that salt-sensitive individuals on high-salt diets showed significantly elevated serum H3K4me1 and Set7 methyltransferase levels—changes absent in salt-resistant controls.

Non-coding RNAs have emerged as equally important regulators. In Dahl S rats, impaired upregulation of miR-429 in the renal medulla under high salt conditions prevents PHD2 mRNA degradation, blunting antihypertensive adaptive responses and worsening SSH; correcting miR-429 function improved pressure natriuresis. In humans, circulating miR-361-5p and miR-362-5p are significantly reduced in salt-sensitive individuals, with miR-361-5p showing diagnostic promise. Urinary exosomal miRNA profiling identified 45 discriminative miRNAs between salt-sensitive and non-salt-sensitive Caucasian subjects. The lncRNA MALAT1 modulates the Keap1-Nrf2 antioxidant axis; sodium promotes MALAT1 expression which upregulates the Nrf2 inhibitor Keap1, increasing oxidative stress—and silencing MALAT1 restores Nrf2-driven antioxidant gene activation.

Prenatal programming is a particularly compelling dimension: maternal malnutrition causes DNA demethylation of AGTR1 (angiotensin II type 1 receptor) in offspring hypothalami, leading to receptor overexpression, heightened sympathetic activity, and lasting blood pressure elevation. These modifications may also be transmitted transgenerationally. The review also highlights that aging accelerates epigenetic drift, compounding SSH risk over time. Encouragingly, some epigenetic marks appear reversible through salt restriction and physical activity, suggesting tangible intervention windows. The authors call for longitudinal human studies and biomarker discovery efforts to translate these mechanistic insights into personalized preventive and therapeutic strategies.